The Royal College of Pharmacy has ended its sponsorship and exhibitor relationship with Teva UK, the British subsidiary of Israeli pharmaceutical firm Teva Pharmaceuticals, ahead of its annual conference next month.
The decision follows pressure from pro-Palestine campaigners who raised concerns about the company's activities. The move makes the Royal College of Pharmacy the second major UK health body to sever ties with Teva under similar activist pressure.
The source material does not specify what those concerns or activities are, nor does it name the first health body to drop the firm or provide detail on the timeline of that earlier decision.